A randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of rFVIIa as adjunctive therapy for control of bleeding in patients with severe blunt trauma: a re-analysis following the exclusion of early (< 48 hours) dea (Q45828639)
Jump to navigation
Jump to search
scientific article published on 7 March 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of rFVIIa as adjunctive therapy for control of bleeding in patients with severe blunt trauma: a re-analysis following the exclusion of early (< 48 hours) dea |
scientific article published on 7 March 2005 |
Statements
1 reference
A randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of rFVIIa as adjunctive therapy for control of bleeding in patients with severe blunt trauma: a re-analysis following the exclusion of early (< 48 hours) deaths (English)
R Rossaint
B Riou
K Boffard
Y Kluger
S Rizoli
B Warren
7 March 2005
1 reference